This Craig-Hallum Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday

Crescent Biopharma CBIO	0.00	0.00%
Cardiff Oncology CRDF	0.00	0.00%
Corsair Gaming CRSR	0.00	0.00%
Caesars CZR	0.00	0.00%
Equity Residential EQR	0.00	0.00%

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

HC Wainwright & Co. analyst Robert Burns downgraded Cardiff Oncology Inc (NASDAQ:CRDF) from Buy to Neutral. Cardiff Oncology shares closed at $1.90 on Monday. See how other analysts view this stock.
HC Wainwright & Co. analyst Mitchell S. Kapoor downgraded Crescent Biopharma Inc (NASDAQ:CBIO) from Buy to Neutral. Crescent Biopharma shares closed at $ 20.65 on Monday. See how other analysts view this stock.
Craig-Hallum analyst Anthony Stoss downgraded Corsair Gaming Inc (NASDAQ:CRSR) from Buy to Hold and announced a price target of $10. Corsair Gaming shares closed at $12.14 on Monday. See how other analysts view this stock.
Evercore ISI Group analyst Steve Sakwa downgraded Equity Residential (NYSE:EQR) from Outperform to In-Line and maintained a price target of $70. Equity Residential shares closed at $65.45 on Monday. See how other analysts view this stock.
Deutsche Bank analyst Carlo Santarelli downgraded Caesars Entertainment Inc (NASDAQ:CZR) from Buy to Hold and cut the price target from $35 to $31. Caesars Entertainment shares closed at $29.05 on Monday. See how other analysts view this stock.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.